| Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 509079 |
NSE Symbol : GUFICBIO |
P/E(TTM) : 57.41 |
|
ISIN Demat : INE742B01025 |
Div & Yield% : 0.03 |
EPS(TTM) : 5.42 |
|
Book Value(₹) : 62.68 |
Market Cap(₹Cr) : 3,120.29 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 819.81 | 806.67 | 690.62 | 779.16 | 487.70 |
| Other Income | 3.62 | 2.18 | 2.57 | 3.10 | 3.73 |
| Stock Adjustments | 24.91 | -0.57 | 33.39 | 19.39 | -14.29 |
| Total Income | 848.34 | 808.28 | 726.58 | 801.65 | 477.14 |
| EXPENDITURE : | |||||
| Raw Materials | 399.62 | 389.32 | 365.21 | 431.35 | 236.00 |
| Power and Fuel Cost | 18.46 | 17.61 | 15.24 | 11.00 | 9.94 |
| Other Manufacturing Expenses | 29.25 | 28.43 | 24.67 | 27.42 | 18.20 |
| Selling and Administration Expenses | 122.19 | 105.28 | 87.63 | 77.97 | 45.93 |
| Miscellaneous Expenses | 11.62 | 8.48 | 9.88 | 17.16 | 13.20 |
| Employee Benefit Expenses | 127.19 | 109.67 | 86.73 | 85.61 | 66.22 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 140.01 | 149.48 | 137.22 | 151.14 | 87.65 |
| Interest | 24.52 | 16.79 | 8.22 | 5.37 | 13.63 |
| Gross Profit | 115.49 | 132.69 | 129.00 | 145.77 | 74.02 |
| Depreciation | 21.06 | 17.02 | 22.28 | 18.93 | 16.31 |
| Profit Before Tax | 94.43 | 115.67 | 106.72 | 126.84 | 57.71 |
| Current Tax | 18.74 | 26.37 | 28.21 | 32.15 | 17.20 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.75 | 3.17 | -1.19 | -1.15 | -3.72 |
| Reported Net Profit | 69.93 | 86.14 | 79.70 | 95.84 | 44.23 |
| Extraordinary Items | 0.09 | -1.67 | 0.02 | 0.05 | 0.02 |
| Adjusted Net Profit | 69.84 | 87.81 | 79.68 | 95.79 | 44.21 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 |
| Profit/Loss Balance carried down | 352.46 | 267.29 | 188.55 | 93.68 | 49.58 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1.00 | 0.97 | 0.97 | 0.97 | 0.39 |
| P & L Balance carried down | 421.39 | 352.46 | 267.29 | 188.55 | 93.68 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Dividend Per Share(Rs) | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| Earnings Per Share-Unit Curr | 6.97 | 8.59 | 8.22 | 9.89 | 4.56 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 59.96 | 53.11 | 35.88 | 27.76 | 17.89 |
| Book Value(Adj)-Unit Curr | 59.96 | 53.11 | 35.88 | 27.76 | 17.89 |